Anders Essen-Möller

Anders Essen-Möller

Net worth: 688 493 $ as of 2026-06-29

85 year
Health Technology
Finance
Technology Services

Profile

Anders Essen-Möller was the founder of Mertiva AB, founded in 1976, where the title held was Director from 2013 to 2014.
Mr. Essen-Möller was the founder of Synectics Medical AB, founded in 2015, where the title held was Chief Executive Officer & Director from 2015 to 2016.
Mr. Essen-Möller is the founder of Diamyd Medical AB, founded in 1996, where the title held is Chief Executive Officer & Director starting in 2026.
Current jobs include Director at Companion Medical, Inc., Director at Diamyd Diagnostics AB, and Director at Armea AB. Former jobs include Chairman at NextCell Pharma AB from 2018 to 2024 and Director at Novakand Pharma AB from 2010 to 2012.
Education includes a graduate degree from the University of Lund.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-03-30 5,297,192 ( 3.95% ) 558 271 $ 2026-06-29
2026-03-30 1,235,620 ( 35.27% ) 130 222 $ 2026-06-29

Anders Essen-Möller active positions

CompaniesPositionStart
DIAMYD MEDICAL AB Founder 1995-12-31
Diamyd Diagnostics AB
Director/Board Member 2011-05-09
Armea AB
Director/Board Member 2011-05-09
Director/Board Member -

Former positions of Anders Essen-Möller

CompaniesPositionEnd
NEXTCELL PHARMA AB Chairman 2024-05-19
Founder 2016-04-09
MERTIVA AB Founder 2014-02-20
KANCERA AB Director/Board Member 2012-03-27
See the detail of Anders Essen-Möller's experience

Training of Anders Essen-Möller

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

36

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies9

Health Technology

Finance

Technology Services

Consumer Services

Health Technology

Health Technology

Diamyd Diagnostics AB

Armea AB

Health Technology

  1. Stock Market
  2. Insiders
  3. Anders Essen-Möller